Cashing in on a brand name
Consumers in the Third World get third-rate treatment from the pharmaceutical industry, who sell them junk in the name of medicine. This includes formulations banned in the parent country of international giants. These companies have adopted a new technique: marketing new formulations under old brand names without informing consumers. These companies exploit people’s faith in brand names and the resistance to generic prescriptions. They also hide behind antiquated laws which do not ban the launch of new formulations using old brand names.
There are currently no refbacks.